The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).

A Vogel; TO Goetze; G Hausner; M Geissler; Gabriele Siegler; LF von Weikersthal; AMR Kestler; M Kleiss; T Muller; A Teufel; J Marquardt; MA Gonzalez-Carmona; DW Mueller; R Eickhoff; EN de Toni; O Waidmann; SE Al-Batran

doi:10.1200/JCO.2021.39.15_suppl.TPS4159

The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).

A Vogel, TO Goetze, G Hausner, M Geissler, Gabriele Siegler, LF von Weikersthal, AMR Kestler, M Kleiss, T Muller, A Teufel, J Marquardt, MA Gonzalez-Carmona, DW Mueller, R Eickhoff, EN de Toni, O Waidmann, SE Al-Batran

Research output: Contribution to journal › Abstract (Journal) › peer-review

3 Citations (Web of Science)

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	39
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS4159
Publication status	Published - 2021

Access to Document

10.1200/JCO.2021.39.15_suppl.TPS4159

Cite this

Vogel, A., Goetze, TO., Hausner, G., Geissler, M., Siegler, G., von Weikersthal, LF., Kestler, AMR., Kleiss, M., Muller, T., Teufel, A., Marquardt, J., Gonzalez-Carmona, MA., Mueller, DW., Eickhoff, R., de Toni, EN., Waidmann, O., & Al-Batran, SE. (2021). The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC). JOURNAL OF CLINICAL ONCOLOGY , 39(15). https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS4159

Vogel, A ; Goetze, TO ; Hausner, G et al. / The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC). In: JOURNAL OF CLINICAL ONCOLOGY 2021 ; Vol. 39, No. 15.

@article{d645d760ccbf49b98ac2998d353c3e90,

title = "The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).",

author = "A Vogel and TO Goetze and G Hausner and M Geissler and Gabriele Siegler and {von Weikersthal}, LF and AMR Kestler and M Kleiss and T Muller and A Teufel and J Marquardt and MA Gonzalez-Carmona and DW Mueller and R Eickhoff and {de Toni}, EN and O Waidmann and SE Al-Batran",

year = "2021",

doi = "10.1200/JCO.2021.39.15_suppl.TPS4159",

language = "English",

volume = "39",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "15",

}

Vogel, A, Goetze, TO, Hausner, G, Geissler, M, Siegler, G, von Weikersthal, LF, Kestler, AMR, Kleiss, M, Muller, T, Teufel, A, Marquardt, J, Gonzalez-Carmona, MA, Mueller, DW, Eickhoff, R, de Toni, EN, Waidmann, O & Al-Batran, SE 2021, 'The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).', JOURNAL OF CLINICAL ONCOLOGY , vol. 39, no. 15. https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS4159

The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC). / Vogel, A; Goetze, TO; Hausner, G et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 39, No. 15, 2021.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC).

AU - Vogel, A

AU - Goetze, TO

AU - Hausner, G

AU - Geissler, M

AU - Siegler, Gabriele

AU - von Weikersthal, LF

AU - Kestler, AMR

AU - Kleiss, M

AU - Muller, T

AU - Teufel, A

AU - Marquardt, J

AU - Gonzalez-Carmona, MA

AU - Mueller, DW

AU - Eickhoff, R

AU - de Toni, EN

AU - Waidmann, O

AU - Al-Batran, SE

PY - 2021

Y1 - 2021

U2 - 10.1200/JCO.2021.39.15_suppl.TPS4159

DO - 10.1200/JCO.2021.39.15_suppl.TPS4159

M3 - Abstract (Journal)

SN - 0732-183X

VL - 39

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 15

ER -

Vogel A, Goetze TO, Hausner G, Geissler M, Siegler G, von Weikersthal LF et al. The IMMULAB trial: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC). JOURNAL OF CLINICAL ONCOLOGY . 2021;39(15). doi: 10.1200/JCO.2021.39.15_suppl.TPS4159